ALMS
ALMS
NASDAQ · Pharmaceuticals

Alumis Inc

$24.51
-0.09 (-0.37%)
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 15 88%
Hold 2 12%
Sell 0 0%
Price Target
Analyst Price Target +0.0% upside
Low Target $15.34
Average Target $24.51
High Target $36.47
Current Price $24.51
Current
$24.51
Target
$24.51
$15.34 $24.51 avg $36.47
Scenario Analysis
Bear Case
$15.34
-37.4%
Low target
Base Case
$24.51
+0.0%
Avg target
Bull Case
$36.47
+48.8%
High target
Risk/Reward
1.3x
Balanced
Price in Context
52-Week High
$30.60
-19.9% from high
52-Week Low
$2.76
+788.0% from low
50-Day SMA
$19.51
+25.6% vs SMA
200-Day SMA
$8.26
+196.7% vs SMA
RSI (14)
60.5
Neutral
Target vs 52W High
$24.51
-19.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%